← FDA DRUG APPROVALS

FDA ANDA · ANDA089000

DIPYRIDAMOLE

Sponsor: GLENMARK GENERICS

APPLICATION
ANDA089000
TYPE
ANDA
ORIGINAL APPROVAL
1991-02-05
LATEST ACTION
1999-05-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DIPYRIDAMOLEDiscontinued
DIPYRIDAMOLE 50MG · TABLET · ORAL

Approval history

1999-05-11Manufacturing (CMC) · Supplement 13AP
1999-05-11Manufacturing (CMC) · Supplement 14AP
1998-11-23Manufacturing (CMC) · Supplement 11AP
1998-11-23Manufacturing (CMC) · Supplement 12AP
1998-05-28Manufacturing (CMC) · Supplement 10AP
1997-03-07Manufacturing (CMC) · Supplement 9AP
1994-09-13Manufacturing (CMC) · Supplement 7AP
1994-08-30Manufacturing (CMC) · Supplement 8AP
1994-05-25Manufacturing (CMC) · Supplement 6AP
1994-05-25Manufacturing (CMC) · Supplement 5AP
1992-06-01Manufacturing (CMC) · Supplement 4AP
1991-03-21Labeling · Supplement 3AP
1991-02-05Labeling · Supplement 1AP
1991-02-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →